MaxCyte stockholders approve 2.3M share increase to equity incentive plan

MAXCYTE, INC.

Stockholders approved amendment to 2022 Equity Incentive Plan increasing authorized shares by 2,300,000.
Plan Amendment passed with ~58.7M votes for, ~10.8M against, ~330K abstentions.
All three board nominees (Brooke, Johnston, Douglas) elected; CohnReznick ratified as auditor.
Amended and Restated 2022 Plan, with details on share counting and award types, filed as Exhibit 10.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.